Ovarian cancer is often called the silent killer because it’s hard to detect until it’s too late.
If found early, however, it’s treatable.
Enter a new blood test, which could be the key to saving thousands of lives each year.
An 11-year study, published in the journal Cancer, tested a new screening strategy for ovarian cancer that focuses on changes in a specific blood protein (one that is a known tumor marker) on over 4000 post-menopausal women.
The study found that the blood test is a highly accurate way to detect ovarian cancer in its early stages.
"Our findings suggest that using a longitudinal (or change over time) screening strategy may be beneficial in post-menopausal women with an average risk of developing ovarian cancer," lead author Karen Lu, MD, said in a press release.
She is currently waiting on the results of a larger, randomized study. "If the results of this study are also positive, then this will result in a change in practice," she said.
That means this new blood test could soon be coming to your doctor’s office, too. It also means ovarian cancer will no longer be a "silent killer."
-Katharine Watts, associate web editor